GENETIC-POLYMORPHISM OF MEPHENYTOIN P(4')-HYDROXYLATION - DIFFERENCE BETWEEN ORIENTALS AND CAUCASIANS

被引：122

作者：

JURIMA, M ^{[1
]}

INABA, T ^{[1
]}

KADAR, D ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO, FAC MED, DEPT PHARMACOL, TORONTO M5S 1A1, ONTARIO, CANADA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 19卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1985.tb02673.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：483 / 487

页数：5

相关论文

共 22 条

[1] ASLANIAN W, 1983, PHARMACOLOGIST, V25, P218
[2] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[3] ELLARD GA, 1976, CLIN PHARMACOL THER, V19, P610
[4] VARIABILITY IN CAFFEINE METABOLISM
GRANT, DM
TANG, BK
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) : 591 - 602
[5] HARADA S, 1980, AM J HUM GENET, V32, P8
[6] HUMAN LIVER ALCOHOL-DEHYDROGENASE ISOENZYME VARIATIONS - IMPROVED SEPARATION METHODS USING PROLONGED HIGH-VOLTAGE STARCH-GEL ELECTROPHORESIS AND ISOELECTRIC-FOCUSING
HARADA, S
AGARWAL, DP
GOEDDE, HW
[J]. HUMAN GENETICS, 1978, 40 (02) : 215 - 220
[7] MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS
INABA, T
JURIMA, M
NAKANO, M
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) : 670 - 676
[8] A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE
INABA, T
NAKANO, M
OTTON, SV
MAHON, WA
KALOW, W
[J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) : 860 - 862
[9] SPARTEINE OXIDATION BY THE HUMAN-LIVER - ABSENCE OF INHIBITION BY MEPHENYTOIN
JURIMA, M
INABA, T
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) : 426 - 428
[10] KALOW W, 1979, CLIN PHARMACOL THER, V26, P766